¸ÎÔàÒÆÖ²ºÍ²¿·Ö¸ÎÇгýÊÇÏÖÔÚÖÎÁƸΰ©¡¢¸ÎÓ²»¯µÈÖÕÄ©ÆÚ¸Î²¡Ê×Ñ¡µÄ×îÓÐÓÃÊֶΡ£¡£¡£¸ÎÔàÔÙÉúÄÜÁ¦ÊǸÎËðÉË¡¢²¿·Ö¸ÎÇгý¼°¸ÎÒÆÖ²ÊõºóÐÞ¸´ÓëÔ¤ºóµÄÒªº¦£¬£¬£¬µ«µ÷¿Ø¸ÎÔÙÉúµÄÓÐÓðеãºÍ¸ÉÔ¤Ò©ÎïØÑ·¦¡£¡£¡£Òò´Ë£¬£¬£¬ÉîÈëÑо¿¸ÎÔÙÉúÆøÖÆÓëDZÔڰеãÓÐÖ÷ÒªÒâÒå¡£¡£¡£
2021Äê8ÔÂ13ÈÕ£¬£¬£¬ngµç×ÓÓÎϷҩѧԺ±Ï»ÝæÏ½ÌÊÚÍŶÓÔÚHepatologyÔÓÖ¾ÔÚÏß½ÒÏþÁËÌâΪ¡°YAP-TEAD mediates peroxisome proliferator-activated receptor ¦Á-induced hepatomegaly and liver regeneration in mice¡±µÄÑо¿ÂÛÎÄ¡£¡£¡£¸ÃÂÛÎÄз¢Ã÷¹ýÑõ»¯ÎïøÌåÔöÖ³ÎD»îÊÜÌå¦Á£¨peroxisome proliferator-activated receptor ¦Á, PPAR¦Á£©Í¨¹ý×÷ÓÃÓÚ¸ÎÔà¾ÞϸµÄ¿ØÖÆÆ÷ºÍÊàŦÐźšª¡ªyesÏà¹ØÂѰף¨yes-associated protein£¬£¬£¬YAP£©£¬£¬£¬Ôö½ø¸ÎÔö´óºÍ¸ÎÔÙÉúµÄй¦Ð§»úÖÆ£¬£¬£¬ÎªPPARa×÷ΪÔö½ø¸ÎÔÙÉúµÄDZÔڰеãÑо¿ÌṩÀíÂÛÒÀ¾ÝºÍÊý¾ÝÖ§³Ö£¬£¬£¬Îª¸ÎÔÙÉúDZÔڰеãµÄÑо¿ÌṩÐÂÊӽǡ£¡£¡£
¸ÃÑо¿ÔÚÒ°ÉúÐÍСÊ󡢸Îϸ°ûÌØÒìÐÔPpar¦ÁÇóý£¨Ppara¦¤Hep£©Ð¡Êó¼°²¿·Ö¸ÎÇгýСÊóÄ£×ÓÉÏÈ·Ö¤ÁËPPAR¦Á¾µä¼¤¶¯¼ÁWY-14643Ôö½ø¸ÎÔàÔö´ó¼°ÔÙÉúµÄ×÷Ó㻣»²¢ÔËÓÃÃâÒß×黯ÆÊÎöÕ¹ÏÖPPAR¦Á¼¤¶¯¿Éµ¼ÖÂСÊó¸ÎÔàÖÐÑë¾²ÂöÇø¸Îϸ°û±ä´óºÍÞ²ÂöÇø¸Îϸ°ûÔöÖ³¡£¡£¡£Í¬Ê±£¬£¬£¬Ó¦ÓÃÃâÒß¹²³ÁµíºÍ¹²¶¨Î»µÈÒªÁì֤ʵPPAR¦ÁÓëYAP¾ßÓÐDZÔÚµÄÏ໥×÷Ó㬣¬£¬PPAR¦ÁµÄE domainÊÇPPAR¦ÁÓëYAPµÄÂѰ׻¥×÷µÄÒªº¦Á¬ÏµÇøÓò£¬£¬£¬PPAR¦Á¼¤¶¯¿ÉÔö½øYAPºËת룬£¬£¬Éϵ÷YAPÏÂÓΰлùÒò¡£¡£¡£½øÒ»²½Ñо¿ÔÚ¸øÓèСÊóYAP-TEADÁ¬ÏµÒÖÖÆ¼ÁÎ¬Ìæ²´·Òºó·¢Ã÷YAPÓëTEADµÄÁ¬ÏµÔÚPPAR¦ÁËùÖ¸ÎÔö´óÖÐʩչÖ÷Òª×÷Ó㬣¬£¬²¢ÔÚAAV-Yap shRNAСÊóºÍ¸ÎÌØÒìÐÔYapÇóý£¨Yap¦¤Hep£©Ð¡ÊóÄ£×ÓÉÏÈ·Ö¤PPAR¦ÁËùÖ¸ÎÔö´óÊÇYAPÒÀÀµÐԵġ£¡£¡£×ÛÉÏËùÊö£¬£¬£¬±¾Ñо¿Ö¤ÊµÁËPPAR¦Á¿Éͨ¹ýÓëYAPDZÔÚµÄÂѰ׻¥×÷¡¢Ôö½øYAPºËתλ¡¢Ó°ÏìYAPÓëTEADÁ¬Ïµ¡¢Éϵ÷YAPÏÂÓΰлùÒò£¬£¬£¬Ôö½ø¸Îϸ°ûÔö´óÓëÔöÖ³£¬£¬£¬½ø¶øÔö½øÐ¡ÊóÐÄÀíÐÔ¸ÎÔö´ó¼°²¿·Ö¸ÎÇгýºó¸ÎÔÙÉú¡£¡£¡£±¾Ñо¿Ð·¢Ã÷PPAR¦Áͨ¹ýYAP-TEADÐźÅÔö½ø¸ÎÔö´óÓë¸ÎÔÙÉúµÄй¦Ð§»úÖÆ£¬£¬£¬ÎªPPAR¦ÁÔö½ø¸ÎÔö´óÓë¸ÎÔÙÉú×÷ÓÃÌṩп´·¨£¬£¬£¬ÎªPPAR¦Á×÷Ϊ¸ÎÔÙÉúDZÔڰеãÌṩ¿ÆÑ§Ö¤¾Ý¡£¡£¡£

¸ÃÍŶÓÓÚ2019ÄêºÍ2021Äê»®·ÖÔÚHepatology ºÍActa Pharmaceutica Sinica B ÉÏÒÔ·âÃæÎÄÕÂÕ¹ÏÖÁËÁíÍâÁ½¸öºËÊÜÌ壨nuclear receptors£¬£¬£¬NRs£©£¬£¬£¬ÔÐÍéXÊÜÌ壨pregnane X receptor, PXR£©ºÍ×é³ÉÐÍÐÛçÞÍéÊÜÌå(constitutive androstane receptor, CAR)£¬£¬£¬Í¨¹ýYAPÐźÅͨ·Ôö½ø¸ÎÔö´óºÍ¸ÎÔÙÉúµÄй¦Ð§»úÖÆ¡£¡£¡£ÏÖÔÚ¹ØÓÚPPAR¦ÁµÄ×îÐÂÑо¿Ð§¹ûÊǸÿÎÌâ×éÔÚºËÊÜÌåÓëYAPµ÷¿Ø¸ÎÔö´óÓë¸ÎÔÙÉúÑо¿ÁìÓòµÄÓÖÒ»Á¦×÷¡£¡£¡£
ngµç×ÓÓÎϷҩѧԺ²©Ê¿Ñо¿Éú·¶Ê˳ɺ͸ßÔÃΪ±¾ÂÛÎĵĵÚÒ»×÷Õߣ¬£¬£¬±Ï»ÝæÏ½ÌÊÚΪÂÛÎĵÄͨѶ×÷Õß¡£¡£¡£ÉÏÊöÑо¿ÊÂÇé»ñµÃ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðί½ÜÇà¼°ÃæÉÏÏîÄ¿¡¢¹ú¼ÒÖØµãÑз¢ÍýÏëÖØµãרÏîµÈ¶àÏî»ù½ðµÄ×ÊÖú¡£¡£¡£
ÂÛÎÄÁ´½Ó£º£º£ºhttps://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.32105